drugset / Trial / NCT05121402
Safety and Efficacy Study of TLL018 in the Treatment of Ulcerative Colitis
RandomizedParallel-groupTriple-blindTreatment
Summary
A study to investigate the safety and efficacy of TLL018 compared with placebo in subjects with moderate to severe ulcerative colitis.
Timeline
- Start
- 2022-12-30
- Primary completion
- 2023-07-01
- Completion
- 2023-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TLL018 | Unknown | — | — |